Riskpilot← Back to searchSign inGet full accessKlemedivasto AB
ABActiveOrg 5569379299Labackavägen 201Dental practice care activities · NACE 8623Est. 20130 employees
Revenue 2024
SEK 2,3M
+47633% vs 2023
EBITDA margin
23.6%
+3171% vs 2023
Equity ratio
18.1%
Financial strength
Net profit 2024
SEK 229K
+973% vs 2023
| Revenue | SEK 2,3M | +47633% |
| EBITDA | SEK 552K | +3171% |
| Net profit | SEK 229K | +973% |
| Total assets | SEK 1,5M | +2954% |
| Equity | SEK 266K | +617% |
| Employees | 0 | — |
Legal name
Klemedivasto AB
Org number
5569379299
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
23 juli 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Bolaget ska bedriva medicinsk verksamhet i egenskap av hälsovård inom uthyrning av personal, utbildning, konsultation i medicinska frågor, äga och förvalta fastigheter och värdepapper samt därmed förenlig verksamhet.
Address
Labackavägen 201
Email
christoffer_kleen@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 71 | 45 | 34 | 5 | 2 339 |
| Staff expenses | — | — | −5 | −1 | −880 |
| EBITDA | −69 | −4 | 0 | −18 | 552 |
| Depreciation & amort. | −5 | −6 | −11 | −8 | −177 |
| EBIT | −74 | −10 | −11 | −26 | 375 |
| Net financials | −1 | −1 | — | — | −65 |
| Profit before tax | −75 | −11 | −11 | −26 | 261 |
| Tax | −0 | −0 | — | — | −31 |
| Net profit | −75 | −11 | −11 | −26 | 229 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 220 | 102 | 76 | 48 | 1 468 |
| Equity | 155 | 94 | 63 | 37 | 266 |
| Long-term debt | 0 | 0 | — | — | 136 |
| Short-term debt | 65 | 8 | 13 | 11 | 1 016 |
| Total debt | 65 | 8 | 13 | 11 | 1 152 |
EBITDA margin
23.6%
This company
15.8%
Market median
+49% vs market
20202024
Equity ratio
18.1%
This company
38.2%
Market median
-53% vs market
20202024
Return on equity
86.0%
This company
18.4%
Market median
+367% vs market
20202024
Net profit margin
9.8%
This company
8.1%
Market median
+21% vs market
20202024
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
20202024
Debt / equity
4.51×
This company
0.62×
Market median
-627% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Klemedivasto AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Izabela Aleksandra Kleen | Board of Directors | 0 companies |
| Rose Elisabeth Kleen | Deputy Board Member | 0 companies |
| Stefan Christoffer Kleen | Chairman | 0 companies |